|1.||Schäfer-Somi, S: 3 articles (05/2014 - 10/2007)|
|2.||Aslan, S: 3 articles (05/2014 - 10/2007)|
|3.||Wehrend, A: 3 articles (08/2008 - 09/2003)|
|4.||Guil-Luna, Silvia: 2 articles (07/2014 - 01/2014)|
|5.||Sánchez-Céspedes, Raquel: 2 articles (07/2014 - 01/2014)|
|6.||Millán, Yolanda: 2 articles (07/2014 - 01/2014)|
|7.||Einspanier, A: 2 articles (05/2014 - 10/2007)|
|8.||Rollón, E: 2 articles (05/2011 - 01/2008)|
|9.||Millán, Y: 2 articles (05/2011 - 01/2008)|
|10.||Pantaleo, Stefania: 1 article (03/2015)|
03/01/2015 - "The aim of this study was to evaluate the effectiveness of a modified aglepristone protocol for the medical treatment of pyometra in the bitch. "
06/01/2010 - "The aim of this study was to evaluate the curative effect of the anti-progestagen aglepristone treatment of pyometra in bitches of different ages. "
12/01/2014 - "A retrospective study of bitches with pyometra, medically treated with aglepristone."
01/01/2013 - "Aglepristone (RU534) is an antiprogestin used for pregnancy termination, parturition induction and conservative pyometra treatment in bitches. "
01/01/2012 - "Pyometra in a six-month-old nulliparous golden hamster (Mesocricetus auratus) treated with aglepristone."
07/01/2014 - "Simple epithelial carcinomas have shorter disease free periods after surgery and a higher reduction of the proliferation index reduction after antiprogestin aglepristone treatment in vivo related to the expression of progesterone receptors (PR). "
01/01/2014 - "These findings suggest that the antiproliferative effects of aglepristone in canine mammary carcinomas are mediated by progesterone receptor isoform A."
01/01/2014 - "Progesterone receptor isoform A may regulate the effects of neoadjuvant aglepristone in canine mammary carcinoma."
05/01/2011 - "Aglepristone decreases proliferation in progesterone receptor-positive canine mammary carcinomas."
01/01/2014 - "This study examined the effects of the antiprogestin aglepristone on cell proliferation and mRNA expression of progesterone receptor isoforms A and B in mammary carcinomas in dogs treated with 20 mg/Kg of aglepristone (n = 22) or vehicle (n = 5) twice before surgery. "
01/01/2005 - "In this study, the efficacy of aglepristone and/or intrauterine antibiotic administration for the treatment of bitches with cystic endometrial hyperplasia/pyometra complex was investigated. "
10/01/2006 - "Clinical evaluation of the use of aglepristone, with or without cloprostenol, to treat cystic endometrial hyperplasia-pyometra complex in bitches."
|4.||Body Weight (Weight, Body)
06/01/2009 - "The cats were treated with aglepristone at a dose of 10mg/kg body weight subcutaneously on days 1, 2, 7 and 14 (if not cured). "
08/01/2008 - "Thirteen European Shorthair pregnant queens were either treated with aglepristone (10 mg/kg body weight; subcutaneously) twice on days 25 and 26 after first mating (am; group I; n = 9), or remained untreated and served as control (group II; n = 4). "
05/01/2014 - "In the AGL group (n=7), aglepristone was administered solely (10mg/kg body weight (BW), subcutaneously, once daily on two consecutive days) whereas in the AGL-CLO group (n=7), aglepristone (dosage as in AGL group) and cloprostenol (1μg/kg BW, subcutaneously, same with aglepristone) were combined. "
04/01/2011 - "For this purpose, pregnancy was terminated in 10 bitches at mid-gestation with the progesterone receptor antagonist aglepristone (10 mg/kg body weight, sc, Alizine®; Virbac, France) at two subsequent days (group IRA = induced resorption/abortion). "
10/01/2011 - "Six experimental groups were defined: group A-5 (n = 12), group A-3.3 (n = 12), group A-2.5 (n = 12) and group A-1.5 (n = 12) in which goats were injected SC once with 5.0, 3.3, 2.5 and 1.5 mg of aglepristone per kg body weight of goat, respectively, group L (n = 11), which was treated IM with 3.75 mg of luprostiol; and group Ct (n = 11), which was injected SC with 1 ml of saline solution. "
09/01/2005 - "In this study, a model for fetal death (FD) was created by administering the antiprogesterone aglepristone twice, at Day 47 and 48 of gestation (n=5). "
09/01/2005 - "Ultrasonographic appearance of the conceptus, fetal heart rate and profiles of pregnancy-associated glycoproteins (PAG) and prostaglandin F2alpha-metabolite (PGF2alpha-metabolite) after induction of fetal death with aglepristone during early gestation in cattle."
10/01/2006 - "In five pregnant beagle bitches, embryonic or fetal death was induced by cloprostenol and cabergoline or by aglepristone. "
|2.||Progesterone Receptors (Progesterone Receptor)
|4.||tranilast (N 5')
|5.||Protein Isoforms (Isoforms)
|6.||Messenger RNA (mRNA)
|10.||Sodium Chloride (Saline Solution)